MedTrace Logo

Local Phase 4 Pan-European SMART Study

NCT00463866 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 8424

Last updated 2010-03-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effect of two different maintenance doses of Symbicort Maintenance And Reliever Therapy (SMART) in adult asthmatic patients. A 6 month treatment period

Conditions

Interventions

DRUG

Budesonide/formoterol

Sponsors & Collaborators

Principal Investigators

  • Michel Aubier, Prof · FRANCE

  • Juliette Ostinelli, MD · AstraZeneca, MC France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Completion
2008-12-31

Countries

  • Belgium
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Russia
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00463866 on ClinicalTrials.gov